Observational studyBMC cancer2025

Utility of the prostest to predict and monitor response to chemotherapy in metastatic Castration-Resistant prostate cancer: A prospective pilot study.

Kambiz Rahbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.